Literature DB >> 26015483

Chlamydia muridarum infection of macrophages elicits bactericidal nitric oxide production via reactive oxygen species and cathepsin B.

Krithika Rajaram1, David E Nelson2.   

Abstract

The ability of certain species of Chlamydia to inhibit the biogenesis of phagolysosomes permits their survival and replication within macrophages. The survival of macrophage-adapted chlamydiae correlates with the multiplicity of infection (MOI), and optimal chlamydial growth occurs in macrophages infected at an MOI of ≤1. In this study, we examined the replicative capacity of Chlamydia muridarum in the RAW 264.7 murine macrophage cell line at different MOIs. C. muridarum productively infected these macrophages at low MOIs but yielded few viable elementary bodies (EBs) when macrophages were infected at a moderate (10) or high (100) MOI. While high MOIs caused cytotoxicity and irreversible host cell death, macrophages infected at a moderate MOI did not show signs of cytotoxicity until late in the infectious cycle. Inhibition of host protein synthesis rescued C. muridarum in macrophages infected at a moderate MOI, implying that chlamydial growth was blocked by activated defense mechanisms. Conditioned medium from these macrophages was antichlamydial and contained elevated levels of interleukin 1β (IL-1β), IL-6, IL-10, and beta interferon (IFN-β). Macrophage activation depended on Toll-like receptor 2 (TLR2) signaling, and cytokine production required live, transcriptionally active chlamydiae. A hydroxyl radical scavenger and inhibitors of inducible nitric oxide synthase (iNOS) and cathepsin B also reversed chlamydial killing. High levels of reactive oxygen species (ROS) led to an increase in cathepsin B activity, and pharmacological inhibition of ROS and cathepsin B reduced iNOS expression. Our data demonstrate that MOI-dependent TLR2 activation of macrophages results in iNOS induction via a novel ROS- and cathepsin-dependent mechanism to facilitate C. muridarum clearance.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26015483      PMCID: PMC4496605          DOI: 10.1128/IAI.00382-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Chlamydia pneumoniae: crossing the barriers?

Authors:  F Blasi; S Centanni; L Allegra
Journal:  Eur Respir J       Date:  2004-04       Impact factor: 16.671

2.  Mutational Analysis of the Chlamydia muridarum Plasticity Zone.

Authors:  Krithika Rajaram; Amanda M Giebel; Evelyn Toh; Shuai Hu; Jasmine H Newman; Sandra G Morrison; Laszlo Kari; Richard P Morrison; David E Nelson
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

3.  The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.

Authors:  R Boer; W R Ulrich; T Klein; B Mirau; S Haas; I Baur
Journal:  Mol Pharmacol       Date:  2000-11       Impact factor: 4.436

4.  Chlamydia psittaci genetic variants differ in virulence by modulation of host immunity.

Authors:  Isao Miyairi; Jonathan D Laxton; Xiaofei Wang; Caroline A Obert; Venkat R R Arva Tatireddigari; Nico van Rooijen; Thomas P Hatch; Gerald I Byrne
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

5.  The infecting dose of Chlamydia muridarum modulates the innate immune response and ascending infection.

Authors:  Heather K Maxion; Wei Liu; Mi-Hyang Chang; Kathleen A Kelly
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

Review 6.  Chlamydia pneumoniae-based atherosclerosis: a smoking gun.

Authors:  Vicky Y Hoymans; Johan M Bosmans; Margareta M Ieven; Christiaan J Vrints
Journal:  Acta Cardiol       Date:  2007-12       Impact factor: 1.718

7.  Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma.

Authors:  Antonio Gigliotti Rothfuchs; Maria Regina Kreuger; Hans Wigzell; Martin E Rottenberg
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

8.  Intracellular survival and persistence of Chlamydia muridarum is determined by macrophage polarization.

Authors:  Eric Gracey; Aifeng Lin; Ali Akram; Basil Chiu; Robert D Inman
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

9.  Amphiphysin IIm is required for survival of Chlamydia pneumoniae in macrophages.

Authors:  Elizabeth S Gold; Randi M Simmons; Timothy W Petersen; Lee Ann Campbell; Cho-Chou Kuo; Alan Aderem
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

Review 10.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03
View more
  19 in total

1.  Beyond Tryptophan Synthase: Identification of Genes That Contribute to Chlamydia trachomatis Survival during Gamma Interferon-Induced Persistence and Reactivation.

Authors:  Matthew K Muramatsu; Julie A Brothwell; Barry D Stein; Timothy E Putman; Daniel D Rockey; David E Nelson
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 2.  Chlamydia Spreading from the Genital Tract to the Gastrointestinal Tract - A Two-Hit Hypothesis.

Authors:  Guangming Zhong
Journal:  Trends Microbiol       Date:  2017-12-27       Impact factor: 17.079

3.  Chlamydia muridarum Induces Pathology in the Female Upper Genital Tract via Distinct Mechanisms.

Authors:  Heze Yu; Hui Lin; Lingxiang Xie; Lingli Tang; Jianlin Chen; Zhiguang Zhou; Jiangdong Ni; Guangming Zhong
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

Review 4.  Sensing the enemy, containing the threat: cell-autonomous immunity to Chlamydia trachomatis.

Authors:  Ryan Finethy; Jörn Coers
Journal:  FEMS Microbiol Rev       Date:  2016-11-01       Impact factor: 16.408

Review 5.  Chlamydial Plasmid-Dependent Pathogenicity.

Authors:  Guangming Zhong
Journal:  Trends Microbiol       Date:  2016-10-03       Impact factor: 17.079

6.  Evidence for cGAS-STING Signaling in the Female Genital Tract Resistance to Chlamydia trachomatis Infection.

Authors:  Xin Su; Hong Xu; Maegan French; Yujie Zhao; Lingli Tang; Xiao-Dong Li; Jianlin Chen; Guangming Zhong
Journal:  Infect Immun       Date:  2022-01-03       Impact factor: 3.609

7.  CCL19-CCR7-dependent reverse transendothelial migration of myeloid cells clears Chlamydia muridarum from the arterial intima.

Authors:  Mark Roufaiel; Eric Gracey; Allan Siu; Su-Ning Zhu; Andrew Lau; Hisham Ibrahim; Marwan Althagafi; Kelly Tai; Sharon J Hyduk; Kateryna O Cybulsky; Sherine Ensan; Angela Li; Rickvinder Besla; Henry M Becker; Haiyan Xiao; Sanjiv A Luther; Robert D Inman; Clinton S Robbins; Jenny Jongstra-Bilen; Myron I Cybulsky
Journal:  Nat Immunol       Date:  2016-09-26       Impact factor: 25.606

8.  Guanylate binding proteins enable rapid activation of canonical and noncanonical inflammasomes in Chlamydia-infected macrophages.

Authors:  Ryan Finethy; Ine Jorgensen; Arun K Haldar; Marcel R de Zoete; Till Strowig; Richard A Flavell; Masahiro Yamamoto; Uma M Nagarajan; Edward A Miao; Jörn Coers
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

9.  ELMO1 Regulates Autophagy Induction and Bacterial Clearance During Enteric Infection.

Authors:  Arup Sarkar; Courtney Tindle; Rama F Pranadinata; Sharon Reed; Lars Eckmann; Thaddeus S Stappenbeck; Peter B Ernst; Soumita Das
Journal:  J Infect Dis       Date:  2017-12-19       Impact factor: 5.226

Review 10.  Immunopathogenesis of genital Chlamydia infection: insights from mouse models.

Authors:  Jacob Dockterman; Jörn Coers
Journal:  Pathog Dis       Date:  2021-03-31       Impact factor: 3.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.